Singapore, Singapore

Yi Quan Zhou

This inventor holds 13 USPTO granted patents and 9 published patent applications and 1 EPO patent. Top assignees: Sap Se, Generos Biopharma Ltd., National University of Singapore. Active years: 2017-2026.

USPTO Granted Patents = 13 

% Patents Active = 76.9


Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 2017-2026

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: Yi Zhou - Innovator in Alzheimer's Disease Treatment

Introduction

Yi Zhou is a prominent inventor based in Singapore, known for his significant contributions to the field of medical research, particularly in the treatment of Alzheimer's disease. With a focus on innovative therapeutic methods, Zhou has made strides in understanding and addressing the complexities of this neurodegenerative condition.

Latest Patents

Yi Zhou holds a patent for "Compositions and methods for treating Alzheimer's disease." This patent discloses methods aimed at treating, preventing, or delaying the onset of Alzheimer's disease by targeting the novel pathway STAT1-CH25H in its pathogenesis. The methods involve administering a pharmaceutically effective amount of a STAT1 inhibitor, a CH25H inhibitor, or a 25-OHC inhibitor, such as simvastatin, a well-known HMG-CoA reductase inhibitor.

Career Highlights

Zhou's career is marked by his dedication to advancing medical science through innovative research. His work has not only contributed to the understanding of Alzheimer's disease but has also paved the way for potential new treatments that could improve the quality of life for patients suffering from this condition.

Collaborations

Throughout his career, Yi Zhou has collaborated with various professionals in the field, including his coworker Xin-Yuan Fu. These collaborations have been instrumental in enhancing the research and development of effective treatments for Alzheimer's disease.

Conclusion

Yi

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…